parkinson’s syge - update · james parkinson, 1817 jean-martin charcot, 1867 clinical...

53
Parkinson’s Syge - Update Kristian Winge Neurologisk Afdeling Sjællands Universitetshospital Roskilde

Upload: others

Post on 21-Jul-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Parkinson’s Syge- Update

Kristian WingeNeurologisk AfdelingSjællands UniversitetshospitalRoskilde

Page 2: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First
Page 3: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Parkinson’s sygdom

Ca 1500 f.Kr.: Indien:

Ayurvedic tekster: Kampavata (Kampa: tremor;

Vata: den væske som styrer bevægelse).

Charaka Samhita: 'Tremors of hands and feet;

difficulty with body movements'.

Behandling: Fava bønner

1500-tallet: Leonardo da Vinci beskrev en

“paralytisk” tilstand med rysten.

1700-tallet: John Hunter, beskrev patienter med

‘severe tremor on awakening who do not complain

from tiredness in the muscles.’

Page 4: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

“The Shaking Palsy” by James Parkinson 1817

James Parkinson, 1817

Jean-Martin Charcot, 1867

Clinical classification and differential diagnosis

Suggests the eponyme “Maladie de Parkinson”

First treatment: belladonna

Friedrich Heinrich Lewy, 1912

Intracytoplamatic inclusions

Constantin Trétiakoff, 1919

Cell loss in the substantia Nigra

Herbert Ehringer og Oleh Hornykiewicz, 1960

Loss of dopamine in the striatum

Donald Calne et al, 1992

British Brain Bank Criteria

Postuma et al. 2015

Evidence based diagnostic criteria

Parkinson J. An Essay on the Shaking Palsy; 1817.

Page 5: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Hvordan udvikler sygdommen sig?

Molekylerne bag sygdommen…….

Patienternes ”Ugens” hotte emne: Cannabis!

Lægens ”Ugens” hotte emne: impuls kontrol forstyrrelser!

Hvad tænker I?

Disposition

Page 6: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Parkinsons sygdomDiagnose

Cellertab i Substantia Nigra

Page 7: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Grundig klinisk undersøgelse

Monitorering af sygdomsforløb

Dopa-challenge/ apomorfin test

Diagnostiske hjælpemidler

Neuro-imaging

MR/CT

SPECT 123I-FP-CIT (Datscan)

Page 8: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Parkinsons sygdom

Page 9: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Terminale del af dopaminergt axon

Dopamin frigivesReceptorer på

modtagercellen

123I-FP-CIT“DAT-skan”

Radioaktivt mærket cocain-derivat med høj affinitet for de præ-synaptiskemono-aminergere-uptake sites.

Præ-synaptiskDopaminTransporterDAT-receptor

Diagnostiske hjælpemidler

Page 10: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

123I-FP-CIT SPECT

KONTROL PARKINSONS SYGDOM

Page 11: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Patient

Rigiditet

Tremor

Bradykinesi

Postural

instabilitet

Parkinsonisme

Page 12: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Terminale del af

dopaminergt axon

Dopamin frigives

Receptorer på

modtagercellen

IBZM & Racloprid

123I-FP-CIT

“DAT-skan”

Diagnostiske hjælpemidler

18F-dopa

11C/18F-DTBZ

Page 13: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

DAT SPECT har en

Specificitet på 88%Sensitivitet på 97%

Diagnostiske hjælpemidler

Page 14: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Patient

Rigidity

Tremor

Bradykinesia

Postural

instability

Parkinsonism

Page 15: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Alpha-synuclein

Amyloid-beta

Tau

Proteiner i Parkinson’s syge

Page 16: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Lewy bodies

Page 17: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Mere end 76 komponenter er hidtil beskrevet i Lewy bodies.

De tilhører ti forskellige protein klasser, herunder

strukturelle proteiner,

alfa-synuclein-bindende proteiner,

synphilin-1-bindende proteiner,

dele af ubiquitin-proteasom systemet,

proteiner involveret i cellulært respons,

proteiner associeret med phosphorylering og signal transduktion,

cytoskeletale proteiner,

cellecyklusproteiner,

cytosoliske proteiner og andre

Page 18: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Det helt dominerede protein i Lewy bodies er α-synuclein.

Består af 140 aminosyrer, <40kDaα –synuclein er et protein som er forbundet med synaptiske vesikler (Maroteaux et al., 1988).

I modsætning til mange andre proteiner involveret i neurodegeneration, er α -synuclein lokaliseret specifikt i nerveterminalen (George et al. 1995; Iwai et al., 1995).

Flere non-neurale væv, herunder erytrocytter (røde blodlegemer) udtrykker også α -synuclein (Barbour et al., 2008), men proteinet er relativt specifikt for nervesystemet (Iwai et al., 1995).

Lewy bodies

Page 19: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Alpha-synuclein i Parkinsonisme

AP

D

CB

D

DL

B

MS

PD

PS

P

Co

ntr

ol

0

5 0 0

1 0 0 0

1 5 0 0

2 0 0 0

CS

F

-sy

nu

cle

in (

pg

/mL

)

* ** *

* *

Heegaard et al., Future Medicine, 2015

Page 20: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First
Page 21: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Levels of total α-synuclein were significantly reduced (P < 0.05) in PD, in contrast to increased levels of α-synuclein oligomers, with a higher oligomeric/total α-synuclein ratio in PD patients when compared with controls (P< 0.001).

A combination of β-glucocerebrosidase activity, oligomeric/total α-synuclein ratio, and age gave the best performance in discriminating PD from neurological controls (sensitivity 82%; specificity 71%, area under the receiver operating characteristic curve = 0.87).

Page 22: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First
Page 23: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First
Page 24: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First
Page 25: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First
Page 26: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Neurologisk Afdeling Roskilde

Page 27: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Parasympaticus:

Tager over når der er ro og fredog især når sympaticus-tonusaftager:

Øger:TarmbevægelserSpytproduktionBlærekontraktionKontraherer pupiller

Nedsætter:PulsRespirationsfrekvens

Neurotransmitter:Acetylkolin

Page 28: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First
Page 29: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First
Page 30: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Parkinsons sygdom

Page 31: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Neuroner

Page 32: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Usmarte nerveceller

Uchihara & Giasson. 2016

Braak et al. 2003b

Vaguskernen

Hukommelsekroppen / fordøjelse

BevægeforstyrrelserLangsomhed, stivhed, rysten

ARVMILJØ

TILFÆLDIGHEDER

Slides venligst udlånt af Per Borghammer,

Aarhus Universitet

Page 33: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Neurologisk Afdeling Roskilde

Page 34: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Usmarte nerveceller

Hjernen selv1% risikoLugtenerven

1% risiko

Vagus5% risiko

Sympatikus2% risiko

VAGUS50% risiko

SYMPATIKUS20% risiko

LUGTENERVEN10% risiko

GIFTSTOF 10 x RISIKO

kontrol (n=66.700)

vagotomi (n=5.300)

-47%

KOMPLET VAGOTOMI

Slides venligst udlånt af Per Borghammer,

Aarhus Universitet

Page 35: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First
Page 36: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First
Page 37: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Neurologisk Afdeling Roskilde

Page 38: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Despite the low sample size and quality of these studies, the data suggest cannabinoid agonists and antagonists are probably ineffective for both LID and motor symptoms although further study using different doses, formulations or target symptoms (e.g. dystonia, psychosis, sleep) may be justified. While there were no serious adverse events reported, side effects included hypotension, vertigo, visual hallucinations, dizziness and somnolence.

Neurologisk Afdeling Roskilde

Cannabis

Page 39: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Neurologisk Afdeling Roskilde

Gør det selv…… ;-)

Page 40: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Neurologisk Afdeling Roskilde

Page 42: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Patient Miljø

MCI

Emotioner

Medicin

ICD

Page 43: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

MCI

Emotioner

Medicin

Page 44: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Medicin

Page 45: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Overordnet er impulskontrol problemer associeret til brugen af dopamin-agonisterne.

Ses også med brug af levo-dopa-præparater.

Hyppighed < 10%, få har betydelige problemer.

Amantadin kan hjælpe.

Mest effektiv er at lægge behandling om, evt. med brug af andre stoffer.

Bispebjerg Hospital – en del af Københavns Universitetshospital

Medicin

Page 46: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Betegnelsen mild cognitive impairment ('let kognitiv svækkelse') angiver, at de mentale funktioner er mere svækkede end normalt for alderen, men personen er ikke dement og den basale praktiske funktionsevne i hverdagen er ikke påvirket.

MCI er ikke en specifik sygdom, men et begreb, der beskriver en tilstand præget af let svækkelse af kognitive funktioner som for eksempel hukommelse, forarbejdningstempo eller mentale styringsfunktioner.

MCI

Page 47: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Definitioner

Page 48: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First
Page 49: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Coping forstås som de mentale og/eller adfærds-mæssige strategier en person bruger til at håndtere nye, svære eller truende situationer.

Det er et komplekst begreb som kan dække over forskellige reaktionsmåder, hvor faktorer som fysiske ressourcer og støtte fra andre kan have indflydelse på valg af strategier i personens håndtering af dagliglivet.

Forskning tyder på, at patienter med PD har forskellige typer af strategier til håndtering af symptomerne på sygdommen, afhængig af personlighed, symptombillede og den uforudsigelighed der følger med PD i det avancerede stadie.

Coping og Parkinsons sygdom

Page 50: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Groft sagt kan vi møde vores verden med brug af to strategier:

• Emotionsfokuseret

• Problemfokuseret

Hos personer med Parkinson er en problemfokuseret strategi var signifikant associeret med bedre QoL i relation til kognitive deficits, kommunikation og kropslig utilpashed (bodily discomfort).

Bucks RS, et al. Int J Geriatr Psychiatry 2011; 26:247-255.

Coping og Parkinsons sygdom

Page 51: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Gruppen i Newcastle undersøgte kognitive funktioner og valg af coping strategier og fandt, at dårligt outcomevar associeret med kognitive deficits og brugen af emotionsfokuseret strategier.

Ydermere fandt man, at graden af kognitive deficits muligvis kan påvirke, hvorledes PD patienter håndterer dagligdagens dilemmaer. Hurt CS et al.,Int Psychogeriatr 2012:1656-1663

Et andet studie af pegede modsat på, at den kognitive status ikke influerede på coping strategierne, men derimod at PD patienter med eksekutive dysfunktioner benyttede forskellige coping strategier i en håndtering af deres kognitive deficits. Montel S, et al. European Journal of Neurology 2008:

1131–1134.

Coping og Parkinsons sygdom

Page 52: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

Patient Miljø

MCI

Emotioner

Medicin

ICD

Page 53: Parkinson’s Syge - Update · James Parkinson, 1817 Jean-Martin Charcot, 1867 Clinical classification and differential diagnosis Suggests the eponyme “Maladie de Parkinson” First

I er velkomne med spørgsmål….

Neurologisk Afdeling Roskilde

Klarede vi det?